For
UK
audiences
The essential guide to product selection
The essential guide to product selection
Topical cytostatic cream preparation with 5% fluorouracil that exerts a beneficial therapeutic effect on neoplastic and pre-neoplastic skin lesions without damaging normal skin. The pattern of response follows this sequence: erythema, vesiculation, erosion, ulceration, necrosis and epithelialisation.
Topical treatment of superficial pre-malignant and malignant skin lesions.
A cutaneous solution containing 5 mg of fluorouracil and 100 mg of salicylic acid per 1g of solution.
Cream containing 5% imiquimod, an immune response modifier that is effective against viral infections and acts as an anti-tumour agent, principally by induction of alpha interferon and other cytokines.
An ointment for actinic keratosis containing 10mg/g tirbanibulin, applied daily over a 5-day course.
After topical application of Metvix (methyl aminolevulinate), porphyrins accumulate intracellularly in the treated skin lesions. The intracellular porphyrins (including PplX) are photoactive, fluorescing compounds and, on light activation in the presence of oxygen, singlet oxygen is formed, which causes damage to cellular compartments, in particular the mitochondria. Light activation of accumulated porphyrins leads to a photochemical reaction and thereby phototoxicity to the light-exposed target cells
An NSAID gel for actinic keratosis containing 3% diclofenac.
Cream with 3.75% imiquimod, is an immune response modifier that is the lead compound of the imidazoline family.